Augmented Reality as Discharge Information for Hospitalized Cardiology Patients

NCT07399379 | Completed

• 2 other identifiers: CEIm 23/44SEC/FEC-INV-CLI 23/12
• Study Type: interventional
• Target: 303
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this clinical trial is to find out whether a simple augmented reality tool provided at hospital discharge can improve patients' understanding of their care, adherence to treatment, and health outcomes, compared with the usual discharge information. This study includes adult patients who are admitted to a cardiology department because of:

• Ischaemic heart disease
• Atrial fibrillation
• Heart failure
• Or who need a pacemaker implantation The main questions this study aims to answer are:
• Does providing augmented reality information at discharge improve patients' perceived quality of care?
• Does it improve patients' adherence to their prescribed treatment?
• Does it reduce major cardiovascular events such as hospital readmission, heart attack, stroke, or cardiovascular death? Researchers will compare two groups of participants:
• A control group, who will receive the usual medical discharge report.
• An intervention group, who will receive the usual medical discharge report plus an information card with a drawing and a QR code that gives access to an augmented reality application. Participants will:
• Receive their discharge information according to the group they are assigned to.
• Use the augmented reality application if they are in the intervention group.
• Be followed over time to assess treatment adherence, patient experience, and cardiovascular events. This is a low-intervention, randomized, single-centre clinical trial conducted in Getafe, Madrid, Spain. Participation in this study does not involve taking any additional medication.

Conditions

Atrial Fibrillation (AF); Myocardial Infarction (MI); Pacemaker Implantation; Heart Failure

Keywords

Augmented reality; Acute Coronary Syndrome; Heart Failure; Pacemaker; PREM; Atrial Fibrillation

Outcome Measures

Primary Outcomes (1)

• PRIMARY OUTCOME: PREM and treatment adherence at one and six months

  To assess PREM (Patient-Reported Experience Measures) in the intervention group and in the control group at discharge and at follow-up.

  Follow up at one and six months from enrollment

Secondary Outcomes (1)

• MACE at one and six months

  From enrollment at one and six months

Study Arms (2)

Intervention Group

ACTIVE COMPARATOR

This group receives the usual medical discharge report plus an information card with a drawing and a QR code that gives access to an augmented reality application explaining their disease.

Device: Augmented reality app

Control group

NO INTERVENTION

This group receives the usual medical discharge report.

Interventions

Augmented reality app DEVICE

The card provided in addition to the usual medical discharge report is designed with a simple drawing that identifies each condition and a QR code. This code can be scanned from any mobile device using the device's camera. Once scanned, a 3D model of a heart or a stent (depending on the condition) appears on the device, showing movement, vibration, and sound as an example of augmented reality. The user can also access simple options through three buttons: 1. Video recorded by a cardiology professional: a brief and easy-to-understand explanation of the patient's condition, lasting approximately 2-3 minutes, provided by a hospital cardiology professional. 2. Treatment recommendations: a drop-down section with a table of discharge recommendations for the patient's condition, including lifestyle and dietary advice. 3. Warning signs: situations that the patient should pay attention to and seek medical advice if they occur.

Intervention Group

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Participants must have access to a mobile device (such as a smartphone or tablet).
• Participants must have been admitted to the Cardiology Department of Getafe University Hospital for ischemic heart disease, heart failure, atrial fibrillation, or pacemaker implantation.

You may not qualify if:

• No access to a mobile device.
• Untreated visual or hearing impairments that prevent viewing or understanding the videos.
• Inability to understand Spanish

Sponsors & Collaborators

• Hospital Universitario Getafe: lead

Study Sites (1)

Hospital Universitario de Getafe

Getafe, Madrid, 28905, Spain

Location

Related Publications (5)

• Davies F. Perceived usefulness, perceived ease of use, and user acceptance of information technology. MIS Quarterly. 1989; 13: 319-40.

  BACKGROUND

• Labanas V, Loukas C, Smailis N, et al. A novel augmented reality simulator for skills assessment in minimal invasive surgery. Surg Endosc. 2015; 29: 2224-34.

  BACKGROUND

• Kang X, Azizian M, Wilson E, et al. Stereoscopic augmented reality for laparoscopic surgery. Surg Endosc. 2014; 28: 2227-35.

  BACKGROUND

• Barroso Osuna, J., & Cabero Almenara, J. (2016). Evaluación de objetos de aprendizaje en Realidad Aumentada: estudio piloto en el grado de Medicina. Enseñanza & Teaching: Revista Interuniversitaria De Didáctica, 34(2), 149-67. https://doi.org/10.14201/et2016342149167.

  BACKGROUND

• Almenara, J.C., Osuna, J.B., Puente, Á.P., et al. Realidad Aumentada para aumentar la formación en la enseñanza de la Medicina. Educ. Medica. Super. 2018; 32 (4): 1-14.

  BACKGROUND

MeSH Terms

Conditions

Myocardial Infarction; Heart Failure; Atrial Fibrillation; Acute Coronary Syndrome

Condition Hierarchy (Ancestors)

Myocardial Ischemia; Heart Diseases; Cardiovascular Diseases; Vascular Diseases; Infarction; Ischemia; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Necrosis; Arrhythmias, Cardiac

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 13, 2026
• First Posted: February 10, 2026
• Study Start: February 23, 2024
• Primary Completion: December 16, 2025
• Study Completion: December 29, 2025
• Last Updated: February 10, 2026

Record last verified: 2026-02

Data Sharing

• IPD Sharing: Will not share

Locations

ES (1)